You are here

Home

Clinical Trials: Digestive System Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, March 30, 2021 - 12:00
Safety of UC-MSC Transfusion for ACLF Patients
Condition:   Acute-On-Chronic Liver Failure
Intervention:   Genetic: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
Sponsor:   Hai Li
Not yet recruiting
Posted: Wednesday, March 10, 2021 - 12:00
Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease
Condition:   Perianal Fistula Due to Crohn's Disease (Disorder)
Intervention:   Drug: Mesenchymal stem cells
Sponsor:   Amy Lightner
Not yet recruiting
Posted: Friday, February 19, 2021 - 12:00
Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease
Condition:   Fatty Liver, Nonalcoholic
Interventions:   Drug: Cilostazol 50 MG;   Drug: Placebo
Sponsor:   Sadat City University
Recruiting
Posted: Wednesday, February 17, 2021 - 12:00
Muscles in Liver Diseases
Condition:   Patients Having a Scheduled Abdominal Surgery Procedure
Interventions:   Other: blood samples;   Other: biopsy of abdominal paroie
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Thursday, February 11, 2021 - 12:00
Treatment of Perianal Fistulas by Endorectal Advancement Flap Associated With Adipose Tissue Injection
Condition:   Anal Fistula
Intervention:   Procedure: Adipose tissue injection associated with endorectal advancement flap.
Sponsor:   Hospital Plató
Recruiting
Posted: Wednesday, December 16, 2020 - 12:00
Conservative Treatment of Gastrointestinal Fistulas by Endoscopic Injection of tSVFem
Condition:   Gastrointestinal Fistula
Intervention:   Procedure: injection of emulsified adipose tissue stromal vascular fraction
Sponsor:   Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
Posted: Monday, September 14, 2020 - 12:00
Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis
Condition:   Crohn Colitis
Interventions:   Drug: remesetemcel-L;   Other: Placebo
Sponsors:   The Cleveland Clinic;   Mesoblast, Inc.
Not yet recruiting
Posted: Thursday, September 10, 2020 - 12:00
Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)
Condition:   Ulcerative Colitis
Interventions:   Drug: Remestemcel-L;   Other: Placebo
Sponsors:   The Cleveland Clinic;   Mesoblast, Inc.
Not yet recruiting
Posted: Thursday, August 20, 2020 - 12:00
Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease
Conditions:   Rectovaginal Fistula;   Crohn Disease;   Crohn Disease of Vulva;   Rectolabial; Fistula
Interventions:   Drug: Mesenchymal Stem Cells;   Other: Placebo
Sponsor:   The Cleveland Clinic
Not yet recruiting
Posted: Thursday, August 20, 2020 - 12:00
Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease
Conditions:   Ileal Pouch;   Crohn Disease
Interventions:   Drug: Mesenchymal stem cells;   Other: Placebo
Sponsor:   The Cleveland Clinic
Not yet recruiting

Pages